Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, ...
BofA lowered the firm’s price target on Thermo Fisher (TMO) to $660 from $675 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech ...
BofA raised the firm’s price target on Thermo Fisher (TMO) to $700 from $650 and keeps a Buy rating on the shares. The firm is updating it price ...
BofA lowered the firm’s price target on Thermo Fisher (TMO) to $545 from $680 and keeps a Buy rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research Organizations ...
Wells Fargo raised the firm’s price target on Thermo Fisher (TMO) to $680 from $660 and keeps an Overweight rating on the shares. Core growth is steadily improving quarter-over-quarter and 2025 ...
Barclays analyst Luke Sergott lowered the firm’s price target on Thermo Fisher (TMO) to $610 from $620 and keeps an Equal Weight rating on the shares after the company reported an in-line quarter ...